US, Korea Join Hands On Precision Meds, MERS Vaccines
This article was originally published in PharmAsia News
South Korea is continuing to step up its fight against infectious diseases. Following the Seoul Declaration after the Global Health Security Agenda meeting in the country last month, it has now reached an agreement with the US NIH to cooperate for the development of precision medicines and MERS vaccines and therapies.
Register for our free email digests: